Lineage Cell Therapeutics, Inc. Liquidation Value

LCTX Other

Cash & Equivalents

$40.79M
As of 2025-12-31
Current Price: N/A

Key Metrics

Cash Liquidation Value

Cash minus Total Obligations
Cash: $40.79M
Total Obligations: -$13.79M
$27.00M
Per share: $0.11
Period: 2025-12-31

Liquid Liquidation Value

Cash + AR minus Total Obligations
Cash: $40.79M
AR: $891,000
Total Obligations: -$13.79M
$27.90M
Per share: $0.11
Period: 2025-12-31

Operating Liquidation Value

Cash + AR + Inventory minus Total Obligations
Cash: $40.79M
AR: $891,000
Inventory: $0
Total Obligations: -$13.79M
$27.90M
Per share: $0.11
Period: 2025-12-31

Build your own liquidation scenario

Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.

Open Calculator →

Liquidation Ladder

MetricTotalPer Share
Cash Liquidation Value$27.00M$0.11
Liquid Liquidation Value$27.90M$0.11
Operating Liquidation Value$27.90M$0.11

Key Components (as of 2025-12-31)

Cash & Equivalents$40.79M
Accounts Receivable$891,000
InventoryN/A
Current Liabilities$11.37M
Long-term DebtN/A
Op. Lease Liability$2.35M
Finance Lease$69,000
Shares Outstanding243.1M

Explore all 179 XBRL tags and build your own scenario → Open Calculator

Historical

PeriodCashARInventoryAPCurr LiabLT DebtOp LeaseFin Lease
2025-12-31$40.79M$891,000N/A$2.34M$11.37MN/A$2.35M$69,000
2025-09-30$40.46M$127,000N/A$1.52M$9.38MN/A$2.54M$83,000
2025-06-30$42.27M$256,000N/A$1.50M$10.76MN/A$2.06M$98,000
2025-03-31$47.89M$213,000N/A$2.00M$13.09MN/A$2.14M$107,000
2024-12-31$45.79M$638,000N/A$1.17M$13.98MN/A$2.39M$122,000
2024-09-30$27.75M$405,000N/A$1.60M$13.86MN/A$2.62M$134,000
2024-06-30$29.62M$235,000N/A$2.39M$15.28MN/A$2.84M$114,000
2024-03-31$43.58M$77,000N/A$2.21M$16.89MN/A$3.13M$128,000

Comments

SEC Filings

PeriodFormFiledLink
2025-12-31 10-K 2026-03-05 View
2025-09-30 10-Q 2025-11-06 View
2025-06-30 10-Q 2025-08-12 View
2025-03-31 10-Q 2025-05-13 View
2024-12-31 10-K 2025-03-10 View
2024-09-30 10-Q 2024-11-14 View
2024-06-30 10-Q 2024-08-08 View
2024-03-31 10-Q 2024-05-09 View

Community Notes

Loading notes...

Questions

Loading questions...